MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin

Gene

Volumn 579, Issue 2, 2016, Pages 146-152

  Zhang, Jiajun ^a   Wang, Sheng ^a   Han, Feng ^a   Li, Jian ^a   Yu, Lan ^a   Zhou, Ping ^a   Chen, Zhijun ^a   Xue, Sheng ^a   Dai, Changyuan ^a   Li, Qingwen ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Bladder cancer; Cell proliferation; Clinicopathological characteristics; MicroRNA 542 3p; Survivin

Indexed keywords

MICRORNA; MICRORNA 542 3P; SURVIVIN; UNCLASSIFIED DRUG; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; MIRN542 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; APOPTOSIS; BIOSYNTHESIS; BLADDER TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICRORNAS; MIDDLE AGED; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 84956936953     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.12.048     Document Type: Article

References (17)

1. Althoff K., Lindner S., Odersky A., Mestdagh P., Beckers A., Karczewski S., Molenaar J.J., Bohrer A., Knauer S., Speleman F., Epple M., Kozlova D., Yoon S., Baek K., Vandesompele J., Eggert A., Schramm A., Schulte J.H. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating survivin. Int. J. Cancer 2015, 136:1308-1320.
2. Catto J.W., Alcaraz A., Bjartell A.S., De Vere W.R., Evans C.P., Fussel S., Hamdy F.C., Kallioniemi O., Mengual L., Schlomm T., Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 2011, 59:671-681.
3. Cho W.C. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 2010, 42:1273-1281.
4. Feng Y., Kang Y., He Y., Liu J., Liang B., Yang P., Yu Z. microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer. BMC Urol. 2014, 14:50.
5. Honma I., Masumori N., Sato E., Takayanagi A., Takahashi A., Itoh N., Tamagawa M., Sato M.A., Tsukamoto T. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology 2004, 64:744-748.
6. Lan H., Lu H., Wang X., Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed. Res. Int. 2015, 2015:125094.
7. Liang Z., Li S., Xu X., Xu X., Wang X., Wu J., Zhu Y., Hu Z., Lin Y., Mao Y., Chen H., Luo J., Liu B., Zheng X., Xie L. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1. Mol. Cell 2015, 38:130-137.
8. Mao X.P., Zhang L.S., Huang B., Zhou S.Y., Liao J., Chen L.W., Qiu S.P., Chen J.X. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer. J. Transl. Med. 2015, 13:86.
9. Oneyama C., Morii E., Okuzaki D., Takahashi Y., Ikeda J., Wakabayashi N., Akamatsu H., Tsujimoto M., Nishida T., Aozasa K., Okada M. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene 2012, 31:1623-1635.
10. Shen X., Si Y., Yang Z., Wang Q., Yuan J., Zhang X. MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. Med. Oncol. 2015, 32:361.
11. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64:9-29.
12. van Rhijn B.W., Burger M., Lotan Y., Solsona E., Stief C.G., Sylvester R.J., Witjes J.A., Zlotta A.R. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur. Urol. 2009, 56:430-442.
13. Wang S., Li Q., Wang K., Dai Y., Yang J., Xue S., Han F., Zhang Q., Liu J., Wu W. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. Clin. Transl. Oncol. 2013, 15:849-854.
14. Wang W.T., Zhao Y.N., Yan J.X., Weng M.Y., Wang Y., Chen Y.Q1., Hong S.J. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J. Hematol. Oncol. 2014, 7:6.
15. Ye F., Wang L., Castillo-Martin M., McBride R., Galsky M.D., Zhu J., Boffetta P., Zhang D.Y., Cordon-Cardo C. Biomarkers for bladder cancer management: present and future. Am. J. Clin. Exp. Urol. 2014, 2:1-14.
16. Yoon S., Choi Y.C., Lee S., Jeong Y., Yoon J., Baek K. Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett. 2010, 584:4048-4052.
17. Zaravinos A. The regulatory role of microRNAs in EMT and cancer. J. Oncol. 2015, 2015:865816.